Search
for
Sort by
Research 151–180 of 275
- Recent approaches of antibody therapeutics in androgenetic alopecia
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- HX109 Herbal Extract Promotes Hair Growth by Regulating Cell Cycle in Hair Follicle Dermal Papilla Cells
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Estrogen and androgen signaling in the pathogenesis of BPH
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
- In vitro 5α-reductase inhibition by selected Ayurvedic herbs for androgenic disorders
- Alternative androgen pathways
- Design, synthesis and anti-tumor evaluation of novel thiohydantoin congeners as androgen receptor antagonists with in vivo study.
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- Primärprävention urologischer Tumore: Prostatakarzinom
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties
- The Role of 5αR Inhibitors in the Early Growth of Pca Cells
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- Detection of the nuclear translocation of androgen receptor using quantitative and automatic cell imaging analysis